- Home
- CSBR vs FLUX Comparison
CSBR vs FLUX Comparison
Compare CSBR & FLUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- FLUX
- Stock Information
- Founded
- CSBR 1985
- FLUX N/A
- Country
- CSBR United States
- FLUX United States
- Employees
- CSBR N/A
- FLUX N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- FLUX Industrial Machinery/Components
- Sector
- CSBR Health Care
- FLUX Miscellaneous
- Exchange
- CSBR Nasdaq
- FLUX Nasdaq
- Market Cap
- CSBR 90.0M
- FLUX 98.5M
- IPO Year
- CSBR 1986
- FLUX N/A
- Fundamental
- Price
- CSBR $6.75
- FLUX $2.16
- Analyst Decision
- CSBR Strong Buy
- FLUX Strong Buy
- Analyst Count
- CSBR 1
- FLUX 2
- Target Price
- CSBR $12.00
- FLUX $6.00
- AVG Volume (30 Days)
- CSBR 11.7K
- FLUX 1.1M
- Earning Date
- CSBR 12-10-2025
- FLUX 11-13-2025
- Dividend Yield
- CSBR N/A
- FLUX N/A
- EPS Growth
- CSBR N/A
- FLUX N/A
- EPS
- CSBR 0.21
- FLUX N/A
- Revenue
- CSBR $56,878,000.00
- FLUX $66,434,000.00
- Revenue This Year
- CSBR $7.31
- FLUX $8.23
- Revenue Next Year
- CSBR $12.01
- FLUX $24.72
- P/E Ratio
- CSBR $31.73
- FLUX N/A
- Revenue Growth
- CSBR 10.11
- FLUX 9.22
- 52 Week Low
- CSBR $4.07
- FLUX $1.15
- 52 Week High
- CSBR $11.99
- FLUX $7.55
- Technical
- Relative Strength Index (RSI)
- CSBR 51.74
- FLUX 33.95
- Support Level
- CSBR $6.65
- FLUX $2.20
- Resistance Level
- CSBR $6.87
- FLUX $2.56
- Average True Range (ATR)
- CSBR 0.16
- FLUX 0.74
- MACD
- CSBR 0.01
- FLUX -0.46
- Stochastic Oscillator
- CSBR 54.55
- FLUX 0.65
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.